Skip Navigation
Skip to contents

Pediatr Gastroenterol Hepatol Nutr.  2017 Jun;20(2):114-123. 10.5223/pghn.2017.20.2.114.

Early Diagnosis of ABCB11 Spectrum Liver Disorders by Next Generation Sequencing

Affiliations
  • 1Department of Pediatrics, Kyungpook National University School of Medicine, Daegu, Korea. neurobaby79@gmail.com
  • 2Department of Pathology, Kyungpook National University School of Medicine, Daegu, Korea.

Abstract

PURPOSE
The goal of this study was the early diagnosis of ABCB11 spectrum liver disorders, especially those focused on benign recurrent intrahepatic cholestasis and progressive familial intrahepatic cholestasis.
METHODS
Fifty patients presenting neonatal cholestasis were evaluated to identify underlying etiologies. Genetic analysis was performed on patients suspected to have syndromic diseases or ABCB11 spectrum liver disorders. Two families with proven ABCB11 spectrum liver disorders were subjected to genetic analyses to confirm the diagnosis and were provided genetic counseling. Whole exome sequencing and Sanger sequencing were performed on the patients and the family members.
RESULTS
Idiopathic or viral hepatitis was diagnosed in 34%, metabolic disease in 20%, total parenteral nutrition induced cholestasis in 16%, extrahepatic biliary atresia in 14%, genetic disease in 10%, neonatal lupus in 2%, congenital syphilis in 2%, and choledochal cyst in 2% of the patients. The patient with progressive familial intrahepatic cholestasis had novel heterozygous mutations of ABCB11 c.11C>G (p.Ser4*) and c.1543A>G (p.Asn515Asp). The patient with benign recurrent intrahepatic cholestasis had homozygous mutations of ABCB11 c.1331T>C (p.Val444Ala) and heterozygous, c.3084A>G (p.Ala1028Ala). Genetic confirmation of ABCB11 spectrum liver disorder led to early liver transplantation in the progressive familial intrahepatic cholestasis patient. In addition, the atypically severe benign recurrent intrahepatic cholestasis patient was able to avoid unnecessary liver transplantation after genetic analysis.
CONCLUSION
ABCB11 spectrum liver disorders can be clinically indistinguishable as they share similar characteristics related to acute episodes. A comprehensive genetic analysis will facilitate optimal diagnosis and treatment.

Keyword

Cholestasis; Jaundice; Hyperbilirubinemia; ABCB11; Mutation; High-throughput nucleotide sequencing

MeSH Terms

Biliary Atresia
Choledochal Cyst
Cholestasis
Cholestasis, Intrahepatic
Diagnosis
Early Diagnosis*
Exome
Genetic Counseling
Hepatitis
High-Throughput Nucleotide Sequencing
Humans
Hyperbilirubinemia
Jaundice
Liver Transplantation
Liver*
Metabolic Diseases
Parenteral Nutrition, Total
Syphilis, Congenital
Full Text Links
  • PGHN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr